Cargando…

Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany

This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases presc...

Descripción completa

Detalles Bibliográficos
Autores principales: Sattler, Sebastian, von dem Knesebeck, Olaf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265319/
https://www.ncbi.nlm.nih.gov/pubmed/35805300
http://dx.doi.org/10.3390/ijerph19137632
_version_ 1784743184116482048
author Sattler, Sebastian
von dem Knesebeck, Olaf
author_facet Sattler, Sebastian
von dem Knesebeck, Olaf
author_sort Sattler, Sebastian
collection PubMed
description This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases prescription drug misuse, especially if employees overcommit. To test these assumptions, we conducted a prospective study using a nationwide web-based sample of the working population in Germany (N = 11,197). Effort, reward, and overcommitment were measured at t(1) and the 12 month frequency of prescription drug misuse for enhancing cognitive performance was measured at a one-year follow-up (t(2)). The results show that 2.6% of the respondents engaged in such drug misuse, of which 22.7% reported frequent misuse. While we found no overall association between misuse frequency and effort, reward, or their imbalance, overcommitment was significantly associated with a higher misuse frequency. Moreover, at low levels of overcommitment, more effort and an effort–reward imbalance discouraged future prescription drug misuse, while higher overcommitment, more effort, and an imbalance increased it. These findings suggest that a stressful work environment is a risk factor for health-endangering behavior, and thereby underlines the importance of identifying groups at risk of misusing drugs.
format Online
Article
Text
id pubmed-9265319
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-92653192022-07-09 Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany Sattler, Sebastian von dem Knesebeck, Olaf Int J Environ Res Public Health Article This study examines how work stress affects the misuse of prescription drugs to augment mental performance without medical necessity (i.e., cognitive enhancement). Based on the effort–reward imbalance model, it can be assumed that a misalignment of effort exerted and rewards received increases prescription drug misuse, especially if employees overcommit. To test these assumptions, we conducted a prospective study using a nationwide web-based sample of the working population in Germany (N = 11,197). Effort, reward, and overcommitment were measured at t(1) and the 12 month frequency of prescription drug misuse for enhancing cognitive performance was measured at a one-year follow-up (t(2)). The results show that 2.6% of the respondents engaged in such drug misuse, of which 22.7% reported frequent misuse. While we found no overall association between misuse frequency and effort, reward, or their imbalance, overcommitment was significantly associated with a higher misuse frequency. Moreover, at low levels of overcommitment, more effort and an effort–reward imbalance discouraged future prescription drug misuse, while higher overcommitment, more effort, and an imbalance increased it. These findings suggest that a stressful work environment is a risk factor for health-endangering behavior, and thereby underlines the importance of identifying groups at risk of misusing drugs. MDPI 2022-06-22 /pmc/articles/PMC9265319/ /pubmed/35805300 http://dx.doi.org/10.3390/ijerph19137632 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Sattler, Sebastian
von dem Knesebeck, Olaf
Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title_full Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title_fullStr Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title_full_unstemmed Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title_short Effort–Reward Imbalance at Work and Prescription Drug Misuse—Prospective Evidence from Germany
title_sort effort–reward imbalance at work and prescription drug misuse—prospective evidence from germany
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265319/
https://www.ncbi.nlm.nih.gov/pubmed/35805300
http://dx.doi.org/10.3390/ijerph19137632
work_keys_str_mv AT sattlersebastian effortrewardimbalanceatworkandprescriptiondrugmisuseprospectiveevidencefromgermany
AT vondemknesebeckolaf effortrewardimbalanceatworkandprescriptiondrugmisuseprospectiveevidencefromgermany